ICU

172 drugs in development·74 companies·1 clinical trial

Drug Pipeline by Phase

Approved(37)
DrugCompany
abriladaPFIZER INC (PFE)
amjevitaAMGEN INC (AMGN)
austedo xrTeva Pharmaceutical Industries Limited (TEVA)
aveedEndo LP (NDOI)
baclofenImpax Laboratories, LLC (IPXL)
baclofenANI PHARMACEUTICALS INC (ANIP)
BelsomraMerck & Co., Inc. (MRK)
brilintaASTRAZENECA PLC (AZN)
cartiformOSIRIS THERAPEUTICS, INC. (OSIR)
carvedilolTeva Pharmaceutical Industries Limited (TEVA)
colestipolANI PHARMACEUTICALS INC (ANIP)
DEFINITYLantheus Holdings, Inc. (LNTH)
doxepinAmneal Pharmaceuticals, Inc. (AMRX)
edluarViatris Inc (VTRS)
fosinoprilTeva Pharmaceutical Industries Limited (TEVA)
fosphenytoinAmneal Pharmaceuticals, Inc. (AMRX)
HeartMate® left ventricular assist device familyABBOTT LABORATORIES (ABT)
hydrocortisoneImpax Laboratories, LLC (IPXL)
isoproterenolAmphastar Pharmaceuticals, Inc. (AMPH)
losartanTeva Pharmaceutical Industries Limited (TEVA)
losartanMylan II B.V. (MYL)
OtrexupAssertio Holdings, Inc. (ASRT)
physiostimOrthofix Medical Inc. Common Stock (DE) (OFIX)
procainamideNEXUS BIOPHARMA INC (NEXS)
propafenoneMylan II B.V. (MYL)
silenorPERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
spydiaViatris Inc (VTRS)
syncardia tahPicard Medical Inc. (PMI)
testosteroneAmneal Pharmaceuticals, Inc. (AMRX)
testosterone enanthateNEXUS BIOPHARMA INC (NEXS)
tetrabenazineDR REDDYS LABORATORIES LTD (RDY)
tofidenceBIOGEN INC. (BIIB)
triamcinolone acetonideTeva Pharmaceutical Industries Limited (TEVA)
valbenazineGreenwich LifeSciences, Inc. (GLSI)
XACDURO®Innoviva, Inc. (INVA)
xeljanz xrPFIZER INC (PFE)
zolpidemTeva Pharmaceutical Industries Limited (TEVA)
Phase 3(62)
DrugCompany
1- Vasopressor - Mean arterial pressure 56-60Valneva SE (VALN)
2- Vasopressor - Mean arterial pressure 61-65Valneva SE (VALN)
3- Vasopressor - Mean arterial pressure 66-70Valneva SE (VALN)
4- Vasopressor - Mean arterial pressure 71-75Valneva SE (VALN)
AbataceptENANTA PHARMACEUTICALS INC (ENTA)
AbataceptCidara Therapeutics, Inc. (CDTX)
AbataceptCrinetics Pharmaceuticals, Inc. (CRNX)
AR-320Aridis Pharmaceuticals, Inc. (ARDS)
axicabtagene ciloleucelGILEAD SCIENCES, INC. (GILD)
bendamustineGENMAB A/S (GNMSF)
bendamustineREGENERON PHARMACEUTICALS, INC. (REGN)
bendamustineWest Pharmaceutical Services Inc. (WST)
bendamustineGenmab A/S (GMAB)
bendamustineJuno Therapeutics, Inc. (JUNO)
cardamystMilestone Pharmaceuticals Inc. (MIST)
elagolixAbbVie Inc. (ABBV)
Empasiprubart IVARGENX SE (ARGX)
fludarabine phosphateFilana Therapeutics Inc. (FLNA)
gamunex-cGrifols S.A. (GRFS)
Inrathecal MorphineCrinetics Pharmaceuticals, Inc. (CRNX)
Intravenous MethadoneCrinetics Pharmaceuticals, Inc. (CRNX)
kte-c19Kite Pharma, Inc. (KITE)
liso-celJuno Therapeutics, Inc. (JUNO)
lymphodepleting chemotherapyNovartis AG (NVS)
Lymphodepleting chemotherapyNovartis AG (NVS)
MosunetuzumabENANTA PHARMACEUTICALS INC (ENTA)
NipocalimabCrinetics Pharmaceuticals, Inc. (CRNX)
nipocalimab sc-livGH Research PLC (GHRS)
obinutuzumabGH Research PLC (GHRS)
obinutuzumabGenmab A/S (GMAB)
obinutuzumabGENMAB A/S (GNMSF)
ObinutuzumabBeOne Medicines Ltd. (ONC)
odronextamabWest Pharmaceutical Services Inc. (WST)
R-CHOPASTRAZENECA PLC (AZN)
R-CVPASTRAZENECA PLC (AZN)
R-CVPMerus N.V. (MRUS)
riliprubartSanofi (SNY)
sp-102SEMNUR PHARMACEUTICALS, INC. (SMNR)
sp-102SCILEX HOLDING CO (SCLX)
SurovatamigMerus N.V. (MRUS)
tak-411Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tazemetostatEpizyme, Inc. (EPZM)
tazverikEpizyme, Inc. (EPZM)
tisagenlecleucelNovartis AG (NVS)
TisagenlecleucelNovartis AG (NVS)
TisagenlecleucelMerus N.V. (MRUS)
TocilizumabCidara Therapeutics, Inc. (CDTX)
ulacamtenCYTOKINETICS INC (CYTK)
UmbralisibASTRAZENECA PLC (AZN)
vclas cryoablation systemAdagio Medical Holdings Inc (ADGM)
vincristineGenmab A/S (GMAB)
vincristineWest Pharmaceutical Services Inc. (WST)
vincristineGENMAB A/S (GNMSF)
vincristineREGENERON PHARMACEUTICALS, INC. (REGN)
vincristineJuno Therapeutics, Inc. (JUNO)
vt cryoablation systemAdagio Medical Holdings Inc (ADGM)
vx-548VERTEX PHARMACEUTICALS INC / MA (VRTX)
xembifyGrifols S.A. (GRFS)
Phase 2(41)
DrugCompany
AcetaminophenMerus N.V. (MRUS)
Axicabtagene CiloleucelCidara Therapeutics, Inc. (CDTX)
Axicabtagene CiloleucelStructure Therapeutics Inc. (GPCR)
Axicabtagene CiloleucelARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Axicabtagene CiloleucelPROTHENA CORP PUBLIC LTD CO (PRTA)
Axicabtagene CiloleucelFilana Therapeutics Inc. (FLNA)
Axicabtagene CiloleucelMerus N.V. (MRUS)
Bendamustine HydrochlorideFATE THERAPEUTICS INC (FATE)
CLDN6 CAR-TBioNTech SE (BNTX)
CLDN6 RNA-LPXBioNTech SE (BNTX)
CLDN6 uRNA-LPX/CLDN6 modRNA-LPXBioNTech SE (BNTX)
DiphenhydraminePROTHENA CORP PUBLIC LTD CO (PRTA)
DiphenhydramineCidara Therapeutics, Inc. (CDTX)
DiphenhydramineMerus N.V. (MRUS)
DiphenhydramineFilana Therapeutics Inc. (FLNA)
etripamil nsMilestone Pharmaceuticals Inc. (MIST)
Express GenesTwist Bioscience Corp (TWST)
Fludarabine phosphateCidara Therapeutics, Inc. (CDTX)
Fludarabine phosphateARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Fludarabine phosphatePROTHENA CORP PUBLIC LTD CO (PRTA)
g100IMMUNE DESIGN CORP. (IMDZ)
IbrutinibENANTA PHARMACEUTICALS INC (ENTA)
Intervention GroupCrinetics Pharmaceuticals, Inc. (CRNX)
Loncastuximab tesirineENANTA PHARMACEUTICALS INC (ENTA)
nipocalimabGH Research PLC (GHRS)
ObinutuzumabCYTOKINETICS INC (CYTK)
ObinutuzumabMerus N.V. (MRUS)
ObinutuzumabFATE THERAPEUTICS INC (FATE)
PYX-107Pyxis Oncology, Inc. (PYXS)
sar445088Sanofi (SNY)
tafasitamabGH Research PLC (GHRS)
tak-411TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
TAK-411Merus N.V. (MRUS)
tazemetostatGH Research PLC (GHRS)
TazemetostatFATE THERAPEUTICS INC (FATE)
UmbralisibFilana Therapeutics Inc. (FLNA)
UmbralisibMerus N.V. (MRUS)
UmbralisibFATE THERAPEUTICS INC (FATE)
VincristineFATE THERAPEUTICS INC (FATE)
Vincristine SulfateFATE THERAPEUTICS INC (FATE)
ZanubrutinibENANTA PHARMACEUTICALS INC (ENTA)
Phase 1/Phase 2(1)
Phase 2/Phase 3(1)

Compare drugs

Frequently asked questions

How many drugs are in development for ICU?

BioSniper tracks 172 drugs in development for ICU across 74 companies.

How many clinical trials target ICU?

There are 1 clinical trial targeting ICU tracked by BioSniper.

Deep-dive into ICU

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis